GRO Biosciences
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $60M
Overview
A synthetic biology platform enabling novel biologics through genetic code expansion and non-standard amino acids.
Synthetic BiologyBiologicsPlatform
Technology Platform
A proprietary platform for genetic code expansion that enables the biosynthesis of proteins containing non-standard amino acids to create novel biologics.
Funding History
1Total raised:$60M
Venture$60M
Opportunities
Potential to unlock new biologic drug modalities and address high-value targets considered 'undruggable' with conventional approaches.
Risk Factors
Platform risk that the technological advantages may not translate into clinically differentiated or manufacturable drugs.
Competitive Landscape
Competes with other advanced protein engineering and synthetic biology platforms in the quest to create best-in-class or first-in-class biologics.